Peripheral Arterial Disease

Clinical Trial Finder

Many patients with peripheral arterial disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Low InTensity Exercise Intervention in PAD

Condition:   Peripheral Artery Disease
Interventions:   Behavioral: Exercise;   Other: Attention control
Sponsors:   Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2015

Delivery of Yamani-15/5 Chemical Solution for PAD

Condition:   Peripheral Arterial Disease
Intervention:   Drug: Yamani-15/5 chemical solution
Sponsor:   Mayo Clinic
Recruiting - verified August 2015

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center (CPC), Denver, Colorado, USA
Recruiting - verified September 2015

Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers

Conditions:   Venous Leg Ulcer;   Chronic Venous Insufficiency;   Venous Stasis Ulcer;   Venous Ulcer;   Venous Insufficiency
Intervention:   Device: Dual Action Pneumatic Compression
Sponsor:   Tactile Medical
Active, not recruiting - verified September 2015

Randomized Phase IIb Trial of DVC1-0101

Conditions:   Intermittent Claudication;   Peripheral Arterial Disease
Intervention:   Drug: DVC1-0101
Sponsors:   Kyushu University;   CPC Clinical Research (Collorado, USA);   Iberica Co. Ltd. (Fukuoka, Japan);   Ministry of Health, Labour and Welfare, Japan
Recruiting - verified September 2015

Efficacy and Safety of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

Conditions:   Peripheral Arterial Disease;   Diabetic Foot
Interventions:   Biological: 3 x 10^6 cells;   Biological: 10 x 10^6 cells;   Biological: 30 x 10^6 cells;   Other: Placebo
Sponsor:   Celgene Corporation
Recruiting - verified August 2015

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Condition:   Peripheral Artery Disease (PAD)
Interventions:   Drug: Ticagrelor;   Drug: Comparator
Sponsors:   AstraZeneca;   CPC Clinical Research
Recruiting - verified August 2015

A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion

Condition:   Acute Peripheral Arterial Occlusion
Interventions:   Biological: Plasmin;   Biological: Plasminogen Activator;   Other: Placebo
Sponsor:   Grifols Therapeutics Inc.
Active, not recruiting - verified August 2015

Get CardioSmart

You're Invited